Mar 02, 2016 8:30am EST OPKO’s GeneDx Presenting on a Number of Topics at the 2016 ACMG Annual Clinical Genetics Meeting
Feb 24, 2016 8:30am EST OPKO's GeneDx Participating in the Molecular Medicine Tri-Conference 2016 in San Francisco
Feb 23, 2016 8:30am EST OPKO Health Announces Dosing of First Patient in Phase 2a Clinical Study of a Long-Acting Factor VIIa for the Treatment of Hemophilia
Feb 23, 2016 8:00am EST OPKO to Announce 2015 Fourth Quarter and Full Year Financial Results on February 29, 2016
Feb 18, 2016 10:49am EST OPKO Health to Present at the RBC Capital Markets Global Healthcare Conference
Feb 09, 2016 8:30am EST Study Demonstrates OPKO’s 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer